:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Isoda, Norikazu, Hew, Lim Yik, Nishikawa, Kazuki, Takaya, Fumihito, Shimazu, Yo, Kobayashi, Daiki, Nabeshima, Kei, Honjyo, Hisako, Esaki, Mana, Okuya, Kosuke, Soda, Kosuke, Ito, Hiroshi, Kumagai, Asuka, Nishiura, Hayate, Hiono, Takahiro, Takakuwa, Hiroki, Usui, Tatsufumi, Ozawa, Makoto, Uchida, Yuko, Onuma, Manabu, Sakoda, Yoshihiro
Format:	Artículo científico
Language:	en
Published:	Pathogens (Basel, Switzerland) 2025
Subjects:	Animals Japan Influenza in Birds Phylogeny Genetic Variation Influenza A virus Seasons Birds Hemagglutinin Glycoproteins, Influenza Virus Chickens
Online Access:	https://pubmed.ncbi.nlm.nih.gov/41011850/
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unexpected Delayed Incursion of Highly Pathogenic Avian Influenza H5N1 (Clade 2.3.4.4b) Into the Antarctic Region.
by: Lisovski, Simeon, et al.
Published: (2024)

Highly pathogenic avian influenza virus (H5N5) detected in an Atlantic walrus () in the Svalbard Archipelago, Norway, 2023.
by: Postel, Alexander, et al.
Published: (2025)

Host-specific functional evolution of seal influenza A virus NS1 protein following avian-to-seal transmission.
by: Kuryshko, Maryna, et al.
Published: (2026)

Detection of Two High Pathogenicity Avian Influenza Virus (HPAIV) Subtypes, H5N1 and H5N5, in a Mass Mortality Event in Wild Seabirds and Co-Location With Dead Seals.
by: Falchieri, Marco, et al.
Published: (2026)

Genomic analysis of high pathogenicity avian influenza viruses from Antarctica reveals multiple introductions from South America.
by: Ogrzewalska, Maria, et al.
Published: (2026)

Influenza vaccination in Brazil: rationale and caveats
by: Sérgio Souza da Cunha
Published: (2005)

Demographic Analysis of Mortality Changes Associated With the COVID‐19 Pandemic in Japan, 2020–2022
by: Yuta Okada, et al.
Published: (2025)

Relação entre morbidade hospitalar e cobertura vacinal contra Influenza A
by: Fernanda Ribeiro Baptista Marques
Published: (2012)

Influenza. Vacunas clásicas y novedosas a las puertas de otra pandemia
by: Raiza Martínez
Published: (2006)

Prevalencia de síntomas parecidos a los de influenza en una ciudad del noreste de México.
by: Jesús Santos-Guzmán
Published: (2011)

Consideraciones para la vacunación en caso de una pandemia de influenza
by: Alba María Ropero Álvarez
Published: (2005)

Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania
by: Lydia M. Mendoza, et al.
Published: (2025)

Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice
by: Sijing Yan, et al.
Published: (2025)

Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024
by: Liliana Antunes, et al.
Published: (2025)

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
by: Lore Merdrignac, et al.
Published: (2024)

Neurologic Complications of Influenza and Potential Protective Vaccine Effects
by: Ann R. Falsey
Published: (2025)

Age‐Related Asymptomatic Rhinovirus Infections Contribute to the Sustained Prevalence in Adults and Are Not Mitigated by Nonpharmaceutical Interventions
by: Dong Wei, et al.
Published: (2026)

Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025
by: Daniel Evans, et al.
Published: (2026)

High Infection Risk Among Health Care Workers During the First SARS‐CoV‐2 Wave in Niamey, Niger
by: Hamidou Lazoumar Ramatoulaye, et al.
Published: (2025)

Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study
by: Kristoffer Grundtvig Skaarup, et al.
Published: (2025)

Incidence of Hospitalization due to Influenza‐Associated Severe Acute Respiratory Infection During 2010–2019 in Bangladesh
by: Mohammad Abdul Aleem, et al.
Published: (2024)

Changes in the Epidemiology of Influenza and Respiratory Syncytial Virus During 2020–2022 Relative to the Pre‐COVID‐19 Pandemic Period (2017–2020) From Systematic Sentinel Syndromic Surveillance in South Africa
by: Sibongile Walaza, et al.
Published: (2026)

Longitudinal SARS‐CoV‐2 Antibody Response in Healthcare Workers: Benefit of Prior Infection and Heterologous Boosting on Anti‐Spike IgG Immunity
by: Els Van Nedervelde, et al.
Published: (2026)

Issue Information
Published: (2025)

Influenza Epidemiology in Finland During and After the COVID‐19 Pandemic: Surveillance Data Analysis (2019–2024)
by: Ulrike Baum, et al.
Published: (2025)

Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season
by: Daniel Aguilar Figueroa, et al.
Published: (2025)

Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain
by: Matilde Zornoza Moreno, et al.
Published: (2024)

Correction to “The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023”
Published: (2026)

The Second Round of a Population‐Based Seroprevalence Study of Anti–SARS‐CoV‐2 Antibodies and COVID‐19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina
by: Jela Aćimović, et al.
Published: (2025)

SARS‐CoV‐2 Viral Load and Cytokine Dynamics Profile as Early Signatures of Long COVID Condition in Hospitalized Individuals
by: Jacobo Alonso Domínguez, et al.
Published: (2025)

Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017–2018 Season and Reveal Age‐Associated Differences in Susceptibility and Antibody‐Binding Specificity
by: Kangchon Kim, et al.
Published: (2024)

Should We Vaccinate Healthcare Workers Against Respiratory Syncytial Virus?
by: Klinger Soares Faico‐Filho, et al.
Published: (2024)

Molecular Analysis of Human Respiratory Syncytial Virus Group B Strains Isolated in Kenya Before and During the Emergence of Pandemic Influenza A/H1N1
by: Julia Wangui, et al.
Published: (2025)

Evaluating COVID‐19 Transmission in a Series of Cases and Contacts in Three Municipalities of Colombia: Insights From the WHO First Few X Protocol, August 2020–January 2021
by: Damaris Heredia, et al.
Published: (2026)

Changing Epidemiological Pattern and Higher Disease Burden of Influenza in China, 2022 to 2025
by: Hairu Yu, et al.
Published: (2025)

An Overview of the H5N1 mRNA Vaccine Pipeline
by: Daniele Focosi, et al.
Published: (2025)

Survival bias and declining mortality risk in long‐term COVID‐19 studies
by: Wiessam Abu Ahmad, et al.
Published: (2026)

Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID‐19, avian influenza, and MERS‐CoV
by: Mona Mahmoud, et al.
Published: (2024)

Sparse Evidence of Influenza C on US Dairy and Beef Cattle Farms
by: Francisco M. Guerra, et al.
Published: (2025)

Burden of Influenza and Cost‐Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India
by: Anand Krishnan, et al.
Published: (2026)